Search

Louise Wang Zhiying Humphrey

Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
627
Issued Applications
267
Pending Applications
54
Abandoned Applications
312

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5582297 [patent_doc_number] => 20090101499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor' [patent_app_type] => utility [patent_app_number] => 11/920782 [patent_app_country] => US [patent_app_date] => 2006-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5700 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20090101499.pdf [firstpage_image] =>[orig_patent_app_number] => 11920782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/920782
Protein-Immobilized membrane, method for immobilization of protein, enzyme-immobilized electrode, and biosensor May 17, 2006 Abandoned
Array ( [id] => 303299 [patent_doc_number] => 07534435 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-19 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 11/411294 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 20304 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534435.pdf [firstpage_image] =>[orig_patent_app_number] => 11411294 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411294
Glycosylated specificity exchangers Apr 25, 2006 Issued
Array ( [id] => 5205020 [patent_doc_number] => 20070026502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Specificity exchangers that redirect antibodies to a pathogen' [patent_app_type] => utility [patent_app_number] => 11/412181 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21686 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026502.pdf [firstpage_image] =>[orig_patent_app_number] => 11412181 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/412181
Specificity exchangers that redirect antibodies to a pathogen Apr 25, 2006 Abandoned
Array ( [id] => 5890407 [patent_doc_number] => 20060276621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Glycosylated specificity exchangers' [patent_app_type] => utility [patent_app_number] => 11/411454 [patent_app_country] => US [patent_app_date] => 2006-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18466 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276621.pdf [firstpage_image] =>[orig_patent_app_number] => 11411454 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/411454
Glycosylated specificity exchangers Apr 25, 2006 Issued
Array ( [id] => 8549047 [patent_doc_number] => 08323928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease' [patent_app_type] => utility [patent_app_number] => 11/277456 [patent_app_country] => US [patent_app_date] => 2006-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 7585 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11277456 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/277456
Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) transactivator of transcription protein for the treatment and prevention of HIV disease Mar 23, 2006 Issued
Array ( [id] => 8257271 [patent_doc_number] => 08206750 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Charged lipoprotein complexes and their uses' [patent_app_type] => utility [patent_app_number] => 11/388135 [patent_app_country] => US [patent_app_date] => 2006-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18874 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11388135 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/388135
Charged lipoprotein complexes and their uses Mar 21, 2006 Issued
Array ( [id] => 5310166 [patent_doc_number] => 20090017447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/909001 [patent_app_country] => US [patent_app_date] => 2006-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23420 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20090017447.pdf [firstpage_image] =>[orig_patent_app_number] => 11909001 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/909001
Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof Mar 19, 2006 Issued
Array ( [id] => 5397355 [patent_doc_number] => 20090317418 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'VACCINES AND METHODS FOR PREVENTION AND TREATMENT OF DRUG-RESISTANT HIV-1 AND HEPATITIS B VIRUS' [patent_app_type] => utility [patent_app_number] => 11/816704 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33109 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317418.pdf [firstpage_image] =>[orig_patent_app_number] => 11816704 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816704
Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus Feb 21, 2006 Issued
Array ( [id] => 5391612 [patent_doc_number] => 20090208925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Methods and Compositions for Determining Hypersusceptibility of HIV-1 to Non-Nucleoside Reverse Transcriptase Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/884667 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18962 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208925.pdf [firstpage_image] =>[orig_patent_app_number] => 11884667 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884667
Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors Feb 15, 2006 Issued
Array ( [id] => 602167 [patent_doc_number] => 07431928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Identification of new CD8 epitopes from HIV-1 proteins' [patent_app_type] => utility [patent_app_number] => 11/339605 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 8254 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/431/07431928.pdf [firstpage_image] =>[orig_patent_app_number] => 11339605 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/339605
Identification of new CD8 epitopes from HIV-1 proteins Jan 25, 2006 Issued
Array ( [id] => 5873008 [patent_doc_number] => 20060165717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'DCchol in newborns' [patent_app_type] => utility [patent_app_number] => 11/338908 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2567 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165717.pdf [firstpage_image] =>[orig_patent_app_number] => 11338908 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/338908
DCchol in newborns Jan 23, 2006 Abandoned
Array ( [id] => 5699622 [patent_doc_number] => 20060216306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Epitopes of human immunodeficiency virus-1' [patent_app_type] => utility [patent_app_number] => 11/302312 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9345 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216306.pdf [firstpage_image] =>[orig_patent_app_number] => 11302312 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/302312
Epitopes of human immunodeficiency virus-1 Dec 11, 2005 Abandoned
Array ( [id] => 5404480 [patent_doc_number] => 20090239794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'HCV F PROTEIN AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/719635 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26450 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239794.pdf [firstpage_image] =>[orig_patent_app_number] => 11719635 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/719635
HCV F PROTEIN AND USES THEREOF Nov 17, 2005 Abandoned
Array ( [id] => 5148760 [patent_doc_number] => 20070048820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-01 [patent_title] => 'Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion' [patent_app_type] => utility [patent_app_number] => 11/258963 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15601 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20070048820.pdf [firstpage_image] =>[orig_patent_app_number] => 11258963 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/258963
Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion Oct 24, 2005 Issued
Array ( [id] => 9238219 [patent_doc_number] => 08603006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Method and apparatus for detecting ineffective inspiratory efforts and improving patient-ventilator interaction' [patent_app_type] => utility [patent_app_number] => 11/664730 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 5989 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11664730 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/664730
Method and apparatus for detecting ineffective inspiratory efforts and improving patient-ventilator interaction Oct 19, 2005 Issued
Array ( [id] => 5799367 [patent_doc_number] => 20060034868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Methods and vaccines for providing in ovo protection against turkey rhinotracheitis' [patent_app_type] => utility [patent_app_number] => 11/251692 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15741 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034868.pdf [firstpage_image] =>[orig_patent_app_number] => 11251692 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251692
Methods and vaccines for providing in ovo protection against turkey rhinotracheitis Oct 16, 2005 Issued
Array ( [id] => 5748619 [patent_doc_number] => 20060111551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Peptide having HTLV-1-specific CTL-inducing activity' [patent_app_type] => utility [patent_app_number] => 11/251195 [patent_app_country] => US [patent_app_date] => 2005-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13190 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111551.pdf [firstpage_image] =>[orig_patent_app_number] => 11251195 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/251195
Peptide having HTLV-1-specific CTL-inducing activity Oct 13, 2005 Abandoned
Array ( [id] => 5807269 [patent_doc_number] => 20060093623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection' [patent_app_type] => utility [patent_app_number] => 11/243094 [patent_app_country] => US [patent_app_date] => 2005-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5128 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20060093623.pdf [firstpage_image] =>[orig_patent_app_number] => 11243094 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/243094
Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection Oct 3, 2005 Abandoned
Array ( [id] => 5648401 [patent_doc_number] => 20060134133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'MVA expressing modified HIV envelope, Gag, and Pol genes' [patent_app_type] => utility [patent_app_number] => 11/238155 [patent_app_country] => US [patent_app_date] => 2005-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 24717 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134133.pdf [firstpage_image] =>[orig_patent_app_number] => 11238155 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/238155
MVA expressing modified HIV envelope, gag, and pol genes Sep 27, 2005 Issued
Array ( [id] => 7776397 [patent_doc_number] => 20120039923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Modified HIV-1 Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/662422 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11979 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039923.pdf [firstpage_image] =>[orig_patent_app_number] => 11662422 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/662422
Modified HIV-1 Envelope Proteins Sep 8, 2005 Abandoned
Menu